Starbucks will stop covering the GLP-1 drugs for weight loss, adding to a broader employer retreat from an increasingly costly benefit.

Starbucks will stop covering the GLP-1 drugs for weight loss, adding to a broader employer retreat from an increasingly costly benefit.

Starbucks has announced that it will stop covering the GLP-1 medications prescribed for weight loss under its employee health plans starting October. According to a report by…